What Antibiotics Provide Pseudomonas Coverage?

Most everyday antibiotics do nothing against Pseudomonas aeruginosa, so doctors keep a short, specific list of drugs that do. That list spans several antibiotic families, including a few pills, though most options are given by IV in the hospital. Being on the list doesn’t guarantee success, because each patient’s strain has to be tested to see which of those drugs it still responds to.

Why Pseudomonas Shrugs Off Most Antibiotics

When doctors say a drug gives “Pseudomonas coverage,” they mean it can reliably kill or stop this particular germ. Every strain of Pseudomonas carries a baseline level of resistance written into its genes.¹ Its outer wall has narrow, selective openings that keep many antibiotic molecules out.² It also has pumps that push many antibiotics back out of the cell before they can work.³ And it makes an enzyme that breaks down some penicillin- and cephalosporin-type antibiotics.⁴

That is why familiar outpatient drugs like amoxicillin or cephalexin don’t help. They either can’t get past the wall or get pumped out. A drug that works well for strep throat or a urinary infection says nothing about whether it will work on Pseudomonas, and this is a common reason doctors switch your antibiotic once Pseudomonas shows up on a culture.

Ertapenem shows the wall at work. It is a carbapenem, the same family as meropenem, yet it has no effect on Pseudomonas, because its molecule is too large to pass through the germ’s narrow wall openings.⁵

Pseudomonas can pick up extra resistance through mutations or by acquiring genes from other bacteria. A long hospital stay with several antibiotic courses gives the germ more chances to do that, so resistance can grow over time.

If your culture says Pseudomonas, that doesn’t always mean infection. The germ is common in water and damp places, and it often affects people who are already ill or hospitalized. It can also sit on skin or in the airways without causing disease. Your doctor decides whether to treat based on your symptoms and where it was found.

The Antibiotics That Cover Pseudomonas

Some drugs that look like they should work do not. Ertapenem does not cover Pseudomonas, unlike its relatives meropenem and imipenem.¹⁴ Switching from meropenem to ertapenem therefore means deliberately dropping Pseudomonas coverage.¹⁵ Tigecycline does not reliably stop Pseudomonas either.¹⁶ Ofloxacin is notably weaker against it than ciprofloxacin or levofloxacin.¹⁷

Chart names can be confusing. Piperacillin-tazobactam is often called Zosyn, meropenem is sold as Merrem, and ciprofloxacin as Cipro. If you see a brand name, ask the nurse for the generic name so you can check it against this list.

Why Your Strain Must Be Tested

Susceptibility testing, the lab test of which drugs work on your strain, starts with a sample such as blood, sputum, urine or a wound swab. The lab uses it to grow the germ, then exposes the bacteria to each drug to see whether the drug stops growth at levels the body can safely reach. Each drug is reported as susceptible, intermediate (borderline) or resistant, and those labels guide the choice. Growing the germ takes time, which is why early treatment is a best guess and the final choice waits for results. Doctors also weigh kidney function, allergies and the infection site, and hospitals keep local records of which drugs their Pseudomonas strains usually respond to.

Not every strain responds to every listed drug. In a large set of hospital samples, about 87% of Pseudomonas strains responded to ceftazidime, 81% to imipenem and 77% to cefepime.¹⁸ Ciprofloxacin and levofloxacin each worked on about 75% of strains in lab testing.¹⁹ Doctors often start a covering drug, then adjust once the strain’s results come back.

Results on paper don’t always match results in patients. Piperacillin-tazobactam cleared pneumonia and bloodstream Pseudomonas in over 90% of cases when the strain was fully sensitive.²⁰ When the strain was borderline, it cleared only half or fewer.²¹

Initial results naming the germ often arrive in one to two days, and drug-by-drug results usually follow a day or two later. Your antibiotic may change then. That is a normal adjustment, not a mistake.

How Each Covering Drug Is Given

Running piperacillin-tazobactam over 3 to 4 hours instead of 30 minutes keeps drug levels effective for longer.²² In very sick patients, 14-day deaths fell from about 32% to 12% with the longer drip.²³ Those patients also left hospital sooner, after about 21 days instead of 38.²⁴

Ciprofloxacin and levofloxacin kill Pseudomonas best at high concentrations.²⁵ Lower levels let surviving germs mutate into resistant forms.²⁶ That’s why taking every pill on schedule and finishing the course matters.

Aminoglycosides given by IV reach the mucus in the airways poorly.²⁷ Inhaled tobramycin delivers the drug straight to the lungs and improves lung function in cystic fibrosis.²⁸ It’s often used in 28-day on, 28-day off cycles to limit resistance.²⁹ Adding inhaled amikacin to IV treatment also helped children with cystic fibrosis flare-ups.³⁰

Options When Pseudomonas Is Resistant

Ceftolozane-tazobactam and ceftazidime-avibactam still work against many multidrug-resistant (MDR) strains, meaning strains resistant to several antibiotic families.³¹ In one large US comparison, ceftolozane-tazobactam succeeded in 61% of patients and ceftazidime-avibactam in 52%.³² Survival at 30 and 90 days was similar between them, though.³³ And in about 1 in 5 patients on either drug, the germ became resistant during treatment.³⁴

Cefiderocol worked against nearly all strains already resistant to both newer combinations, in lab testing.³⁵ But strains carrying certain enzymes that destroy carbapenems resisted almost all combination drugs, with 4% or fewer responding.³⁶ Knowing whether a strain makes these enzymes shapes the choice.

Colistin and polymyxin B are old drugs brought back for germs resistant to everything else.³⁷ The pumps that defeat most antibiotics don’t work against polymyxins.³⁸ They can harm the kidneys, a known concern doctors monitor.³⁹

Is Aztreonam a Good Choice

When aztreonam was the first drug tried, treatment failed in about 78% of patients versus 42% on other similar drugs.⁴⁰ It also more often had to be switched once lab results came back, 61% versus 28%.⁴¹

Those figures describe aztreonam as a first-guess drug, used before the strain was known. Once testing shows the strain is susceptible, it can be a reasonable choice.

It is often chosen for people with severe penicillin allergies. Aztreonam is not a penicillin and rarely cross-reacts with penicillin allergy, which is why it stays on the list for people who cannot take other beta-lactams. Many “penicillin allergies” are not true allergies, so allergy testing can widen the options. If you’re on aztreonam, ask whether your strain’s results support it.

One Antibiotic or Two

In over 1,100 patients with Pseudomonas bloodstream infections, 30-day deaths were about 17% with one drug or two.⁴² Combining drugs didn’t lower relapse or resistance.⁴³ Pooled results for blood and lung infections also showed no overall survival difference.⁴⁴

Some results favor combinations. Higher-quality studies within that pooled analysis did find more deaths on a single drug.⁴⁵ One hospital study found combination therapy cut the risk of death substantially.⁴⁶

Studies differ in which patients they include, which drugs they compare and how sick the patients were, so their results can point in different directions. Studies that only look back at records can also be skewed, because sicker patients are often the ones given two drugs. There is no universal rule, and guidelines tend to leave room for the doctor’s judgment.

Doctors often start with two drugs for another reason: it raises the chance that at least one works before results return, and many patients step down to one once they arrive. Extra drugs add side effects, such as kidney strain from aminoglycosides.

Why Some Pseudomonas Infections Keep Coming Back

Pseudomonas can form a biofilm, clumps of bacteria wrapped in slime they produce.⁴⁷ These clumps are hard or impossible to eradicate with antibiotics.⁴⁸ Bacteria inside grow slowly and tolerate drugs, and they also fend off the immune system.⁴⁹ This happens in cystic fibrosis and COPD lungs, long-term bladder catheters, breathing tubes and chronic wounds.⁵⁰

A lab result of “susceptible” can therefore overstate how well the drug will work in a long-standing infection. Doctors may choose longer courses or higher-dose and inhaled routes to push drug concentrations up where the slime sits.

Treating early helps. Inhaled tobramycin can clear early Pseudomonas infection before it settles in.⁵¹ In children with cystic fibrosis, adding oral ciprofloxacin didn’t improve clearance over inhaled tobramycin alone.⁵²

With chronic infection, the goal shifts from cure to keeping bacterial levels and flare-ups down. Removing or replacing catheters can matter as much as drugs, and wound care and airway clearance support the antibiotics.

Where Pseudomonas Comes From in Hospitals

Sink drains in intensive care units are frequently colonized with Pseudomonas.⁵³ Sink traps have spread resistant Pseudomonas to patients.⁵⁴ Water splashing from a contaminated drain can land on nearby surfaces, equipment or hands, and staff hands or shared equipment can then carry the germ to patients. The germ most often causes pneumonia in people with chronic lung disease, ICU patients and those with weak immune systems.⁵⁵

If you’re visiting a hospitalized relative, ask staff before placing belongings near sinks. Hand washing by visitors and staff limits spread. At home, keep nebulizers and humidifiers clean and dry.